Yonhap Infomax NewsJan 28
Hanmi Pharmaceutical has signed an exclusive deal to export its GLP-1 obesity drug and diabetes treatments to Mexico’s largest private pharma firm, expanding its global reach in metabolic disease therapies.
#YonhapInfomax #HanmiPharmaceutical #Efpeglenatide #LaboratoriosSanfer #GLP1 #DiabetesTreatment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102383
Hanmi Pharmaceutical Exports Obesity Drug to Mexican Pharma Firm

Hanmi Pharmaceutical has signed an exclusive deal to export its GLP-1 obesity drug and diabetes treatments to Mexico’s largest private pharma firm, expanding its global reach in metabolic disease therapies.

Yonhap Infomax